Methylphenidate Hydrochloride: Clinical Trials

6 trials of Methylphenidate Hydrochloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 4, Recruiting 1, Unknown 1

Follow Methylphenidate Hydrochloride: new trials by email Literature Review of Methylphenidate Hydrochloride trials Research Report on Methylphenidate Hydrochloride

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylphenidate in KBG Syndrome: N-of-1 Series
Methylphenidate Hydrochloride, Placebo - Kbg Syndrome, ADHD - Combined Type
Phase 4RecruitingRadboud University Medical Center152024-11-132026-08-11
FASST - Fetal Alcohol Spectrum Stimulant Trial
Methylphenidate Hydrochloride, Placebo, Methylphenidate hydrochloride - Fetal Alcohol Spectrum Disorders
Phase 4UnknownMonash Medical Centre202022-02-142022-12-13
Real World Evidence of the Efficacy and Safety of FOQUEST
Methylphenidate Hydrochloride, Lisdexamfetamine Dimesylate - Attention Deficit-Hyperactivity Disorder
Phase 4CompletedPurdue Pharma, Canada2572019-09-192021-09-16
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride, Placebo - Attention-deficit/Hyperactivity Disorder
Phase 4CompletedShire4642012-04-172021-06-08
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride, Placebo - Attention-deficit/Hyperactivity Disorder
Phase 4CompletedShire5492012-04-032021-06-10
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate
methylphenidate hydrochloride, OROS methylphenidate hydrochloride (CONCERTA) - Attention Deficit Hyperactivity Disorder
Phase 4CompletedMassachusetts General Hospital502003-07-012011-07-12

Conditions studied

Attention Deficit Disorder with Hyperactivity (5)  ·  Fetal Alcohol Spectrum Disorders (1)  ·  KBG syndrome (1)

Sponsors

Shire (2)  ·  Massachusetts General Hospital (1)  ·  Monash Medical Centre (1)  ·  Purdue Pharma, Canada (1)  ·  Radboud University Medical Center (1)

Countries

United States (3)  ·  Canada (2)  ·  Australia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

Alison Crichton, PhD (1)  ·  Thomas Spencer, MD (1)

Results publications

PMID 28980198, PMID 38631835